# Immune Resistance Interrogation Study

> **NCT04243720** · — · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 100 (estimated)

## Conditions studied

- Cancer
- Solid Tumor
- Metastatic Cancer
- Immune Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04243720
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-26
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04243720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04243720, "Immune Resistance Interrogation Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04243720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*